| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Eszter Ostorhazi | |
| Laszlo Otvos | |||
| P2860 | cites work | Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 | Q22010648 |
| A -defensin mutation causes black coat color in domestic dogs | Q24606634 | ||
| Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections | Q24607197 | ||
| LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 | ||
| Neonatal host defense against Staphylococcal infections | Q26823812 | ||
| Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance | Q26991811 | ||
| Antimicrobial compounds in tears | Q27026893 | ||
| Wound healing activity of the human antimicrobial peptide LL37 | Q57713408 | ||
| Biochemical and antibacterial analysis of human wound and blister fluid | Q28277537 | ||
| Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway | Q28541612 | ||
| LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations | Q30555350 | ||
| Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment | Q33526956 | ||
| Synergy and duality in peptide antibiotic mechanisms | Q33796466 | ||
| Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors | Q34198845 | ||
| Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections | Q34308017 | ||
| Tissue repair and the dynamics of the extracellular matrix. | Q34314606 | ||
| Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds | Q34326463 | ||
| Innate defense regulator peptide 1018 in wound healing and wound infection | Q34373912 | ||
| 1,25-dihydroxyvitamin D3 induces LL-37 and HBD-2 production in keratinocytes from diabetic foot ulcers promoting wound healing: an in vitro model | Q34388526 | ||
| The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts | Q34453545 | ||
| Physiology and healing dynamics of chronic cutaneous wounds | Q34475825 | ||
| New perspectives for natural antimicrobial peptides: application as antinflammatory drugs in a murine model | Q34479717 | ||
| Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skin | Q34510667 | ||
| An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. | Q34534186 | ||
| From innate immunity to de-novo designed antimicrobial peptides | Q34595485 | ||
| Lactoferrin, a bird's eye view | Q34637860 | ||
| Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. | Q34679033 | ||
| A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties | Q35005890 | ||
| Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus) | Q35097174 | ||
| A small peptide with potential ability to promote wound healing | Q35125207 | ||
| Lactoferricin derived from milk protein lactoferrin | Q35137699 | ||
| What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? | Q35143463 | ||
| Antimicrobial peptides and the skin | Q35753531 | ||
| Taking inventory: antibacterial agents currently at or beyond phase 1. | Q35903238 | ||
| Impact of LL-37 on anti-infective immunity. | Q35966461 | ||
| Activity, expression and genetic variation of canine β-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs. | Q35976019 | ||
| Antibacterial peptides and proteins with multiple cellular targets | Q36214382 | ||
| Cationic host defense (antimicrobial) peptides | Q36335785 | ||
| Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris | Q36428610 | ||
| Antibacterial peptides for therapeutic use: obstacles and realistic outlook | Q36556909 | ||
| Trauma-related infections in battlefield casualties from Iraq | Q36800879 | ||
| The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds | Q36977156 | ||
| Designer self-assembling Peptide nanofiber scaffolds for study of 3-d cell biology and beyond | Q37013900 | ||
| Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice | Q37036569 | ||
| AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense | Q37393392 | ||
| Discovery and development of a synthetic peptide derived from lactoferrin for clinical use. | Q37914350 | ||
| Antimicrobial peptides: agents of border protection for companion animals. | Q37992673 | ||
| Immune modulation by multifaceted cationic host defense (antimicrobial) peptides | Q38162670 | ||
| Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents | Q38209134 | ||
| Polymers and formulation strategies of nanofibrous systems for drug delivery application and tissue engineering. | Q38267055 | ||
| Epigenetically altered wound healing in keloid fibroblasts. | Q38343232 | ||
| Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot Therapy | Q38644671 | ||
| Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus | Q38848646 | ||
| Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection | Q38982372 | ||
| The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor | Q39040413 | ||
| The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins | Q39069783 | ||
| Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli | Q39653098 | ||
| BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore | Q39681307 | ||
| Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes | Q39903865 | ||
| Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris | Q40023939 | ||
| Cutaneous scars: Part I. | Q40656152 | ||
| The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study | Q40700026 | ||
| Identification of synthetic host defense peptide mimics that exert dual antimicrobial and anti-inflammatory activities | Q41426276 | ||
| Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome | Q41739821 | ||
| Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens | Q41892470 | ||
| Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases | Q42111353 | ||
| Therapeutic antimicrobial peptides may compromise natural immunity | Q42184235 | ||
| Antimicrobial peptides as therapeutic agents | Q42223000 | ||
| Innate immune cocktail partially protects broilers against cellulitis and septicemia | Q42275592 | ||
| Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. | Q43150485 | ||
| The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models | Q43209556 | ||
| The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding | Q43547658 | ||
| Lifestyle drug market booming | Q44121360 | ||
| Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells | Q44220826 | ||
| Antimicrobial peptides stage a comeback | Q44370091 | ||
| Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne | Q45180265 | ||
| A self-assembling peptide reduces glial scarring, attenuates post-traumatic inflammation and promotes neurological recovery following spinal cord injury | Q45797456 | ||
| HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair | Q46162282 | ||
| Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream | Q46260034 | ||
| Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models | Q46684777 | ||
| Antimicrobial peptides: an emerging concept in cutaneous biology | Q47744473 | ||
| Altered expression of antimicrobial peptide genes in the skin of dogs with atopic dermatitis and other inflammatory skin conditions. | Q50967870 | ||
| Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. | Q51027523 | ||
| Increased proliferation in keloid fibroblasts wounded in vitro. | Q51116115 | ||
| Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. | Q51375703 | ||
| Helix stability confers salt resistance upon helical antimicrobial peptides. | Q53645072 | ||
| Pexiganan acetate. | Q54109833 | ||
| Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers | Q57177960 | ||
| P433 | issue | 7 | |
| P921 | main subject | wound healing | Q1509074 |
| P304 | page(s) | 871-881 | |
| P577 | publication date | 2015-04-03 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Therapeutic utility of antibacterial peptides in wound healing | |
| P478 | volume | 13 |
| Q58728409 | Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development |
| Q34507671 | Antimicrobial peptides and wound healing: biological and therapeutic considerations |
| Q89571075 | Bioinspired Designs, Molecular Premise and Tools for Evaluating the Ecological Importance of Antimicrobial Peptides |
| Q37710376 | In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs |
| Q38855258 | Insect-derived short proline-rich and murine cathelicidin-related antimicrobial peptides act synergistically on Gram-negative bacteria in vitro |
| Q40635352 | Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides |
| Q40594176 | Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice. |
| Q91651339 | Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model |
| Q47224789 | Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa |
| Q41102387 | Racing on the Wrong Track |
| Q58781151 | Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens and |
| Q38726045 | Topical antimicrobial agents for treating foot ulcers in people with diabetes |
Search more.